Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented

POSTED: Feb. 7, 2012 Share

In this 10-minute video interview, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Antoni Ribas discuss recent findings that can be used to develop new treatments for advanced squamous cell carcinoma. He also explains how MEK inhibitor drugs in clinical trials can now also be used to treat the disease. (From

Last updated: 7/27/2012 1:32:53 PM